Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$257M |
| 2 |
JPMorgan Chase
JPM
|
+$211M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
Home Depot
HD
|
+$183M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$182M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
Meta Platforms (Facebook)
META
|
+$132M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$129M |
| 4 |
NVIDIA
NVDA
|
+$127M |
| 5 |
Merck
MRK
|
+$108M |
Sector Composition
| 1 | Healthcare | 14.98% |
| 2 | Technology | 13.18% |
| 3 | Financials | 12.05% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Celanese
CE
$4.89B
| $36.1M | 0.05% |
418,022
+297,128
| +246% | +$25.7M |
|
302
Acuity Brands
AYI
$10.1B
| $35.8M | 0.05% |
373,743
+264,675
| +243% | +$25.3M |
|
303
Cirrus Logic
CRUS
$5.98B
| $35.7M | 0.05% |
577,148
+448,977
| +350% | +$27.7M |
|
|
IPOC.U
304
DELISTED
Social Capital Hedosophia Holdings Corp. III Units, each consisting of one Class A ordinary share an
IPOC.U
| $35.6M | 0.05% |
+3,000,001
| New | +$35.6M |
|
305
Norwegian Cruise Line
NCLH
$11.5B
| $35.6M | 0.05% |
+2,167,101
| New | +$35.6M |
|
306
Ameriprise Financial
AMP
$46.5B
| $35.6M | 0.05% |
236,982
+194,130
| +453% | +$29.1M |
|
307
Omnicom Group
OMC
$15.1B
| $35.5M | 0.05% |
649,452
+426,496
| +191% | +$23.3M |
|
308
Eli Lilly
LLY
$673B
| $35.4M | 0.05% |
215,915
+196,369
| +1,005% | +$32.2M |
|
309
VICI Properties
VICI
$35.3B
| $35.4M | 0.05% |
1,753,181
+1,716,798
| +4,719% | +$34.7M |
|
310
iShares MBS ETF
MBB
$41.4B
| $35.4M | 0.05% |
319,590
+314,875
| +6,678% | +$34.9M |
|
311
UDR
UDR
$12.9B
| $35.3M | 0.05% |
943,123
-82,728
| -8% | -$3.09M |
|
312
Northern Trust
NTRS
$24.6B
| $35.2M | 0.05% |
443,694
+214,925
| +94% | +$17.1M |
|
313
Moderna
MRNA
$9.52B
| $35.2M | 0.05% |
547,977
-68,434
| -11% | -$4.39M |
|
314
AES
AES
$9.06B
| $35.2M | 0.05% |
2,427,947
+1,285,451
| +113% | +$18.6M |
|
315
Apellis Pharmaceuticals
APLS
$3.39B
| $35.1M | 0.05% |
1,075,250
-282,336
| -21% | -$9.22M |
|
316
Royalty Pharma
RPRX
$15.8B
| $35M | 0.05% |
+721,802
| New | +$35M |
|
317
Marriott International Class A Common Stock
MAR
$71.7B
| $34.8M | 0.05% |
406,477
-82,247
| -17% | -$7.05M |
|
318
Thermo Fisher Scientific
TMO
$182B
| $34.8M | 0.05% |
96,131
+82,996
| +632% | +$30.1M |
|
319
Axalta
AXTA
$6.8B
| $34.6M | 0.05% |
1,533,971
+378,941
| +33% | +$8.55M |
|
320
Freeport-McMoran
FCX
$63B
| $34.6M | 0.05% |
2,988,802
+1,306,397
| +78% | +$15.1M |
|
321
Plug Power
PLUG
$1.63B
| $34.5M | 0.05% |
4,202,917
+3,101,576
| +282% | +$25.5M |
|
322
Black Hills Corp
BKH
$4.27B
| $34.3M | 0.05% |
604,715
+467,642
| +341% | +$26.5M |
|
323
Tesla
TSLA
$1.12T
| $34.3M | 0.05% |
475,830
-1,320,990
| -74% | -$95.1M |
|
324
Janus Henderson
JHG
$6.91B
| $33.9M | 0.05% |
1,599,864
+1,316,918
| +465% | +$27.9M |
|
325
CONMED
CNMD
$1.67B
| $33.7M | 0.05% |
467,630
-76,400
| -14% | -$5.5M |
|